Radiopharma maker Lantheus weighs potential $7 billion sale after Curium offer
Bloomberg reports that US radiopharmaceutical maker Lantheus Holdings is weighing a preliminary buyout offer worth approximately USD 7 billion from rival Curium. The company is also in talks with other potential bidders. Lantheus shares jumped 12.8 percent in after-hours trading on the report.
Investing.com Americas3 h agoLNTH